IMPACT OF HBV INTEGRATION EVENTS IN HBV-RELATED HEPATOCELLULAR CARCINOMA AFTER LONG-TERM ANTIVIRAL THERAPY ON CLINICAL INDICATORS AND HUMAN CHROMOSOMAL STRUCTURE

被引：0
|
作者：
Hu, Bobin [1 ]
Wang, Hang [1 ]
Liang, Hengkai [1 ]
Wang, Rongming [1 ]
Wei, Lu [1 ]
Su, Tumei [1 ]
Li, Qingmei [1 ]
Yin, Qianbin [1 ]
Feng, Yanfei [1 ]
Su, Minghua [1 ]
Jiang, Jianning [1 ]
机构：
[1] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
762
引用
收藏
页码：S570 / S571
页数：2
相关论文
共 50 条
  • [31] Prophylactic Antiviral Therapy Before Hepatectomy Is Beneficial to HBV-Related Hepatocellular Carcinoma Patients with Negative HBV-DNA: Comments on Statistical Analysis of the Study
    Ramakrishna, H. K.
    INDIAN JOURNAL OF SURGERY, 2022, 84 (05) : 1136 - 1137
  • [32] Prophylactic Antiviral Therapy Before Hepatectomy Is Beneficial to HBV-Related Hepatocellular Carcinoma Patients with Negative HBV-DNA: Comments on Statistical Analysis of the Study
    Ramakrishna HK
    Indian Journal of Surgery, 2022, 84 : 1136 - 1137
  • [33] Better prognosis of hepatic resection combined with antiviral therapy for HBV-related hepatocellular carcinoma with BCLC Stage B/C
    Wei, Qin
    Tian, Huan
    Luo, Huan-xian
    Zhang, Ying-cai
    Deng, Yi-nan
    Yao, Jia
    Li, Hua
    Chen, Gui-hua
    Yang, Yang
    ASIAN JOURNAL OF SURGERY, 2017, 40 (06) : 453 - 462
  • [34] A wide-margin liver resection improves long-term outcomes for patients with HBV-related hepatocellular carcinoma with microvascular invasion
    Yang, Pinghua
    Si, Anfeng
    Yang, Jue
    Cheng, Zhangjun
    Wang, Kui
    Li, Jun
    Xia, Yong
    Zhang, Baohua
    Pawlik, Timothy M.
    Lau, Wan Yee
    Shen, Feng
    SURGERY, 2019, 165 (04) : 721 - 730
  • [35] Incidence of YMDD mutants, hepatocellular carcinoma and hepatic decompensation in patients with HBV-related cirrhosis treated long-term with lamivudine monotherapy
    Lampertico, P
    Vigano', M
    Romeo, R
    Del Ninno, E
    Colombo, M
    GASTROENTEROLOGY, 2001, 120 (05) : A572 - A573
  • [36] Incidence of YMDD mutants, hepatocellular carcinoma and hepatic decompensation in patients with HBV-related cirrhosis treated long-term with lamivudine monotherapy
    Lampertico, P
    Vigano, M
    Romeo, R
    Iavarone, M
    Del Ninno, E
    Colombo, M
    JOURNAL OF HEPATOLOGY, 2001, 34 : 149 - 149
  • [37] Long-term clinical benefit of Peg-IFNα and NAs sequential antiviral therapy on HBV related HCC
    Qi, Wen-Qian
    Zhang, Qian
    Wang, Xu
    Xu, Yan
    Zhao, Ping
    Guo, Hong-Hua
    Zhou, Chang-Yu
    Sun, Yu
    Liu, Lin
    Wang, Jiang-Bin
    NEOPLASMA, 2021, 68 (01) : 200 - 207
  • [38] Prognosis and Risk Factors of Recurrence in HBV-Related Small Hepatocellular Carcinoma After Stereotactic Body Radiation Therapy
    Han, Yifan
    Liu, Jianxiang
    Pan, Jiali
    Chen, Hongyu
    Tan, Ning
    Kang, Qian
    Yang, Yuqing
    Xu, Xiaoyuan
    Li, Wengang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [39] Nucleos(t)ide analogue therapy in relation to survival after transarterial chemoembolization for HBV-related hepatocellular carcinoma
    Lee, Teng-Yu
    Chen, Yi-Ju
    Lin, Jaw-Town
    Ho, Hsiu-Jon
    Wu, Ming-Shiang
    Wu, Chun-Ying
    HEPATOLOGY, 2015, 62 : 385A - 385A
  • [40] Editorial: clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for HBV
    Stratton, Leanne
    Bathgate, Andrew
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (08) : 879 - 880
12345